key: cord-0871241-18rz2k37
authors: Tan, Ayse
title: Synthesis, spectroscopic characterization of novel phthalimides derivatives bearing a 1,2,3-triazole unit and examination as potential SARS-CoV-2 inhibitors via in silico studies
date: 2022-08-05
journal: J Mol Struct
DOI: 10.1016/j.molstruc.2022.132915
sha: 51b74c52fabf2ac692b0205d7201f2ef6680f580
doc_id: 871241
cord_uid: 18rz2k37

In the present study, novel phthalimide derivatives 8(a-f) and 9(a-f) bearing a 1,2,3-triazole subunit were synthesized via CuAAC reactions and characterized by (1)H, (13)C NMR, HR-MS, and FT-IR analyses. To support the fight against SARS-CoV-2, in silico molecular docking studies were carried out to examine their interactions with the proteins of SARS-CoV-2 (Mpro and PLpro) and the protein-protein interactions (PPI) between the ACE2-spike (S1) in comparison with various inhibitors reported to be active by in vitro experiments. The ligand-protein stabilities of compounds 8a-Mpro, 8b-PLpro, and 9a-‘ACE2-S1’ showing the best binding energy and predicted inhibition constant values (Ki) were examined by molecular dynamics simulation studies. Finally, in silico ADMET properties of the target compounds were investigated using the Swiss ADME and ProTox-II web tools. According to in silico results, all phthalimide analogs may block the PPI between S1 and ACE2. The compounds may also inhibit the progression of the Mpro, and PLpro proteins of SARS-CoV-2. Additionally, it has been estimated that the compounds are suitable for oral administration and exhibit low levels of toxicity.

Since a new type of coronavirus disease, COVID-19 caused by SARS-CoV-2 virus, emerged in December 2019 in China[1], scientists have conducted many studies on the mechanism of action of the SARS-CoV-2 in the human body. The spike (S) protein of SARS-CoV-2 has been reported to promote virus entry into the host cell by binding with the human ACE2 protein [2] . The S protein comprises two subunits: S1 and S2. The S1 facilities the binding to ACE2 of the virus and it consists of the receptor-binding domain (RBD), the N-terminal domain (NTD) , and the other several subdomains, while the S2 mediates virus-cell membrane fusion and initiates the infection [3] [4] [5] . The S1 binds to ACE2 via its RBD part [6, 7] . Blocking of the protein-protein interactions (PPI) between the S1 and ACE2 can impair infection efficiency [8] , therefore, this blockade has been considered as a possible drug target [9] . After the virus enters the host cell, viral replication and transcription are initiated by the other proteins of SARS-CoV-2 [10, 11] . The main protease protein (Mpro or 3CLpro) of the virus is considered an attractive drug target because it is required in the processing and maturation of viral polyproteins [12] . The papain-like protease protein (PLpro), which is another viral protease of the virus, plays an important role in both the cleavage for the proliferation cycle of viral polyproteins and the disruption of host responses [13, 14] .

Therefore, the PLpro has been reported as an attractive drug target [15] , as well. In silico approaches have been used to discover potential inhibitors of SARS-CoV-2 by scientists. The interactions of both commercially available antiviral drugs and some known bioactive compounds with the proteins (especially, Mpro and PLpro) of SARS-CoV-2 have been examined via in silico studies [15] [16] [17] [18] . Recently, the synthesis of some new compounds containing various bioactive moieties such as 1,2,3-triazole, Schiff base, piperidine, and norcantharimides have been reported by scientists and some of these compounds have been suggested as possible therapeutic agents for the COVID-19 via in silico studies [19] [20] [21] . In addition to in silico studies, it has been reported in vitro antiviral studies against SARS-CoV-2 [22] .

Phthalimide is a core structure of some pharmaceutically active compounds (Figure 1 ). The phthalimide framework is used as starting materials for the synthesis of the compounds, such as alkaloids, polymers, pesticides, and copolymers [23] . 4-amino phthalimide derivatives are known for their strong fluorescent properties [24, 25] . Phthalimide derivatives are also known to have potent biological activities, such as anti-HIV, anticancer, anti-inflammatory, CK2 inhibitory, hypoglycemic, antioxidant anticonvulsant, antimalarial, antiviral, histone deacetylase inhibitory, cholinesterase inhibitory, and COX inhibitory [26] [27] [28] [29] [30] [31] [32] . The 1,2,3-triazole ring constitutes the basic building block of many organic and inorganic molecules having various bioactive properties, such as antitubercular, antifungal, anticancer, anti-HIV, antibacterial, antimicrobial, anti-inflammatory, antiallergic, xanthine oxidase (XO) inhibitory, and IDO inhibitory [33] [34] [35] [36] [37] [38] [39] (Figure 2 ). The 1,2,3-triazole ring is resistant to oxidation-reduction and hydrolysis reactions in acidic or basic media due to their high aromatic stability [35] . In recent years, the 1,2,3-triazole compounds have been used as a key motif in many fields, such as polymer chemistry, materials science, and drug discovery [40, 41] . The primary and secondary amines, another bioactive subunits, have been reported to have favorable effects on the biological activities of some hybrid molecules [29, 37, [42] [43] [44] . In the light of these studies, in the present study, novel hybrid phthalimide derivatives 8(a-f) and 9(a-f) bearing 1,2,3-triazole subunit having three active components (the phthalimide ring, various amines, and 1,2,3-triazole ring) were synthesized. To support the fight against SARS-CoV-2, in silico molecular modeling studies were carried out to examine their interactions with the PPI of ACE2-S1 and the proteins of SARS-CoV-2 (Mpro and PLpro) by comparison with various inhibitors reported to be active in vitro experiments.

Novel hybrid phthalimide analogs bearing a 1,2,3-triazole framework were regioselectively synthesized via Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) [34, 36, 45] . For this purpose, phthalimide was reacted with propargyl bromide in the presence of K 2 CO 3 in acetonitrile at 75 ºC to obtain compound 1 [46] (Scheme 1).

Scheme 1 Synthesis of compounds 8(a-f) and 9(a-f). Reagents and conditions: (a) Propargyl bromide, K 2 CO 3 , acetonitrile, 75 ºC, (b) Chloroacetyl chloride, NaHCO 3 , acetonitrile, 0 ºC, (c) NaN 3 , dimethyl sulfoxide, r.t., (d) CuSO 4 .5H 2 O, sodium L-ascorbate, methanol:water (1:1), r.t.

On the other hand, corresponding organic azido compounds 6(a-f) [42, 43, 47] and 7(a-f) [48] [49] [50] [51] , which are known in the literature, were synthesized by the reaction steps given in Scheme 1. For this, in the first step, 4(af) and 5(a-f) were synthesized from the reaction of various amines (secondary amines 2(a-f) and primary amines 3(a-f)) with chloroacetyl chloride in the presence of NaHCO 3 in acetonitrile at 0 ºC. In the second step, 2-chloro-N-substituted acetamide derivatives 4(a-f) and 5(a-f) were treated with NaN 3 in dimethyl sulfoxide at room temperature and azido compounds 6(a-f) and 7(a-f) were obtained in good yields. Finally, compound 1 was treated with azido compounds 6(a-f) or 7(a-f) in the presence of CuSO 4 .5H 2 O [45] and sodium L-ascorbate in a methanol:water solvent system at room temperature, and the target compounds (8(a-f) and 9(a-f)) were obtained in good yields (Scheme 1).

The structures of phthalimide-1,2,3-triazole hybrid compounds 8(a-f) and 9(a-f) are similar. Among these compounds, 8a and 9a were chosen as the model compounds. The 1 H NMR spectrum of the compound 8a was recorded in CDCl 3 and the 13 C NMR spectrum of 8a was recorded in CDCl 3 /DMSO-d 6 

Molecular docking studies play an important role in explaining the protein-ligand relationship [52] [53] [54] and prevent both in vitro and in vivo studies of molecules that are impossible to be effective, thus the studies provide great financial savings. In the present studies, the interactions of the target compounds with SARS-CoV-2 proteins were examined and their estimated Ki values were calculated via molecular docking studies. For this purpose. The interactions of the target compounds with the PPI of ACE2-S1, Mpro, and PLpro proteins were investigated. PDB files: 6M0J for the ACE2-S1, 7K40 for the Mpro, and 7CMD for the PLpro were used.

Bojadzic et al. [9] have reported that methylene blue (MB) (IC 50 : 3.03 µM) inhibits the PPI of between the S1 and ACE2. Therefore, MB was used as a reference inhibitor/ligand. The target compounds and MB were docked on the PPI of ACE2-S1. According to the docking results, all target compounds showed better interactions than MB with the PPI. The binding energy values vary between -6.40 and -9.70 kcal/mol, while the estimated Ki values vary between 0.077 and 20.35 µM. The best binding energy and estimated Ki values of MB were -6.18 kcal/mol and 29.32 µM. Compound 9a in the target compounds exhibited the best binding energy (-9.70 kcal/mol) and estimated Ki value (0.077 µM) (Table 1) . According to the docking results, MB interacted with the RDB of ACE2, while compound 9a interacted with both the RDB of ACE2 and S1. The phthalimide moiety of 9a formed a conventional hydrogen bond with Lys353 residue (3.00 Å) of the ACE2, its triazole ring formed a π-anion with Asp38 residue (3.92 Å) of the ACE2 protein. The phthalimide moiety of 9a also formed a π-cation interaction with Arg403 (3.91 Å) and a carbon-hydrogen bond with Tyr495 residue (2.97 Å) of the S1 protein.

At the same time, while the carbonyl group of amide moiety of 9a formed a conventional hydrogen bond with Ser494 residue (2.07 Å) of the S1 protein, its benzyl group formed a π-alkyl interaction with Leu452 (5.28 Å) of the S1. 9a also formed van der Waals interactions with both the ACE2 and S1 proteins (Figures 3 and 6 ).

The Mpro protein of SARS-CoV-2 are necessary for maturation, viral polyproteins processing [12] , and it has been recognized as an important drug target. Therefore, all target compounds were docked on the active site of the Mpro protein (PDB ID: 7K40) containing boceprevir as a co-crystallized ligand. The docking mode of 7K40 was determined according to the location of boceprevir using a directed docking procedure. The validation study was carried out for boceprevir and the root mean square deviation (RMSD) value was 1.630 Å (see SI, Figure   S49 -a). This value shows to be valid for the docking procedure. Boceprevir was also used as a reference inhibitor/ligand, it has been reported to inhibit the Mpro protein (IC 50 : 8.0 µM) [12] . For all target compounds, (Table 1) . When the results were examined in detail, the triazole ring of 8b formed a conventional hydrogen bond with Gln269 (2.02 Å), a π-π stacked with Tyr264 (3.69 Å). The triazole ring also formed π-anion and carbon-hydrogen bond interactions with Asp164 (4.25 Å and 3.77 Å, respectively). The phthalimide moiety formed two amide-π-stacked interactions with Gly163 (3.67 Å and 4.55 Å), π-anion with Glu167 (4.94 Å), πalkyl with Leu162 (5.42 Å), and π-sigma interaction with Gln269 (3.64 Å). Its pyrrolidine ring formed an alkyl interaction with Arg166 (4.57 Å) (Figures 5 and 6 ).

In this study, the interactions of the respective inhibitors (Figure 7 ) with all proteins were investigated at the same time. Both the interactions of MB with the Mpro and PLpro proteins and the interactions of boceprevir with the PPI of ACE2-S1 complex are weaker than the target compounds. Regarding GRL0617, while it showed weaker than the target compounds in the interactions with the PPI of the ACE2-S1, it showed the binding energy value close to the target compounds in the interactions with Mpro. Multi-targeting inhibitors can be beneficial for solving limited efficiencies, resistant profiles of an individual target. Therefore, the target compounds can be considered as effective inhibitors than the respective inhibitors against all three proteins (Table 1) . (Figures 11a and 11 b) . Tyr273 is the most important one in terms of H-bonds for 8b-PLpro (Figures 11c   and 11d) . A: His34, A: Glu35, A: Asp38, A: Lys353, E: Ser494, and E: Gly496 are the most important ones in terms of H-bonds for 9a-'ACE2-S1' (Figures 11e and 11f) . 

In silico ADME studies of compounds 8(a-f) and 9(a-f) were performed to predict their physicochemical descriptors using the Swiss ADME website [56] . Some of the ADME values of the compounds are given in Table 2 and the bioavailability radar images are shown in Figure S48 (see SI). The colored zone in the bioavailability radar image is the convenient physicochemical region for oral bioavailability [29] According to this, while compounds 8c, 8d, 9b are very soluble in the water, the other compounds are soluble in the water. All compounds have high GI absorption and do not cross the blood-brain barrier (BBB). The BBB diffusion is a crucial parameter due to toxicity, therefore the target compounds may be considered as good drug candidates. While compounds 8(a-c), 9a, 9c, and 9e act as P-glycoprotein substrates, compounds 8d, 8e, 8f, 9b, and 9e do not act as P-glycoprotein substrates. All compounds obey the Lipinski, Ghose, Veber, Egan, and Muegge rules. In silico toxicity predictions of the target compounds were evaluated through the ProTox-II [57] [58] [59] , which is a free website. The oral rat acute toxicity (LD 50 ) values of the target compounds were predicted as 500 mg/kg, and the predicted toxicity classes of all were 4 ( Table 2 ). These predicted results mean that the target compounds show low toxicity profiles. 

All reagents and anhydrous solvents were purchased from Sigma-Aldrich, Alpha, Acros, and Merck and used without further purification. The 1 H NMR and 13 C NMR spectra were recorded on a Bruker (Avance III) 400

MHz NMRspectrometer. The FT-IR spectrum was recorded with a Perkin Elmer spectrophotometer using an ATR head in the range of 4000-600 cm -1 . Melting point (M.p.) was measured with a Thermo Scientific melting point device. The mass spectra were recorded on an Agilent Technologies 6530 Accurate-Mass Q-TOF LC/MS.

Compounds 1, 4(a-f), 5(a-f), 6(a-f), and 7(a-f) were sythesized as mentioned in previous studies [42, 43, [46] [47] [48] [49] [50] [51] .

To a stirred solution of compound 1 (1 mmol) in 20 mL of methanol were added 6(a-f) or 7(a-f) (1 mmol) and [68, 69] was used in the simulation.

The models were made neutral by adding counter ions where needed. To mimic the physiological conditions, 0.15 M salt (NaCl) was added. The NPT [70, 71] ensemble with 300 K temperature and 1 atm pressure were selected for complete simulation. The models were relaxed before the simulation. The trajectories were saved after every 100 ps for analysis, and the stability of simulations was evaluated by calculating the RMSD of the protein and ligand over time.

In summary, novel phthalimide analogs 8(a-f) and 9(a-f) bearing a 1,2,3-triazole framework were synthesized via CuAAC in good yields and characterized by various spectroscopic methods. The interactions with the proteins of SARS-CoV-2 (Mpro and PLpro) and the PPI between ACE2-S1 of the target compounds were examined via the molecular docking studies by comparison with MB, boceprevir, and GRL0617 inhibitors. All phthalimide analogs showed better interactions than MB in the interactions with the PPI of ACE2-S1 and compound 9a in the target compounds exhibited the best binding energy value (-9.70 kcal/mol) and estimated Ki value (0.077 µM). In the interactions with the Mpro protein, compound 8a showed the best binding energy (-8.76 kcal/mol) and estimated Ki value (0.379 µM). Regarding the interactions with the PLpro, compound 8b exhibited the best binding energy (-8.87 kcal/mol) and estimated Ki value (0.315 µM) in the target compounds.

The ligand-protein stabilities of compounds 8a-Mpro, 8b-PLpro, and 9a-'ACE2-S1' showing the best binding energy and predicted Ki were investigated via the molecular dynamics simulation studies. The stabilities of 8a-Mpro, 8b-PLpro, and 9a-'ACE2-S1' support the docking results. Finally, in silico ADMET studies were carried out. According to the predicted results, the target compounds have acceptable pharmacokinetic profiles and are suitable for oral administration. The compounds were estimated to display low toxicity levels. According to the in silico results, the target compounds may prevent the entry of SARS-CoV-2 into the host-cell, and the progression of the Mpro and PLpro proteins. Therefore, the compounds can be evaluated in vitro and in vivo studies as potential inhibitors of SARS-CoV-2.

The online version contains supplementary material available at …..

The author is grateful to Mus Alparslan University. 1 H and 13 C NMR analyses at Giresun University, HR-MS analyses at Ataturk University were performed with a fee.

Ayse Tan: Conceptualization, methodology, design, synthesis, characterization, in silico studies, writing-draft, and editing

All data are included in the manuscript and provided as Supplementary Information

The author declares no competing interests.

-oxo-2-(pyrrolidin-1-yl)ethyl)-1H-1,2,3-triazol-4-yl)methyl)isoindoline-1,3-dione (8b)

21 (s, 2H), 5.03 (s, 2H), 3.70-3.69 (m, 4H), 3.64-3.61 (m, 2H), 3.57-3.55 (m, 2H), 13 C NMR (δ, ppm, 100 MHz

38 (s, 2H), 4.84 (s, 2H), 3.02 (s, 3H), 2.83 (s, 3H), 13 C NMR (δ, ppm, 100 MHz

03 (s, 2H), 3.41 (q, J = 7.2 Hz, 4H), 1.26 (t, J = 7.2 Hz, 3H), 1.14 (t, J = 7.2 Hz, 3H), 13 C NMR (δ, ppm, 100 MHz

3-dioxoisoindolin-2-yl)methyl)-1H-1,2,3-triazol-1-yl)acetamide (8f)

Hz, 3H), 0.91 (t, J =7.2 Hz, 3H), 13 C NMR (δ, ppm

3-dioxoisoindolin-2-yl)methyl)-1H-1,2,3-triazol-1-yl)acetamide (9a)

CDCl 3 ): 7.86-7.84 (m, 3H), 7.74-7.72 (m, 2H), 7.30-7.24 (m, 3H), 7.19 (d, J = 7.2 Hz, 2H)

3-dioxoisoindolin-2-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-ethylacetamide (9b)

Yield: 90%, white crystals, mp: 171-173 º C, 1 H NMR (δ, ppm

CDCl 3 ): 7.89-7.87 (m, 2H), 7.77-7.74 (m, 3H), 6.07 (s, 1H), 5.02 (d, J=10.8 Hz, 4H), 3.20 (q, J=6.8 Hz, 2H), 1.49 (h, J=7.6 Hz, 2H), 0.85 (t, J=7.2 Hz, 3H), 13 C NMR (δ, ppm, 100 MHz

3-dioxoisoindolin-2-yl)methyl)-1H-1,2,3-triazol-1-yl)acetamide (9d)

3-dioxoisoindolin-2-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-isopropylacetamide (9e)

3-dioxoisoindolin-2-yl)methyl)-1H-1,2,3-triazol-1-yl)acetamide (9f)

82 (s, NH), 5.03 (s, 2H), 4.91 (s, 2H), 1.32 (s, 9H), 13 C NMR (δ, ppm, 100 MHz

Molecular Docking Studies

AutoDock 4.2 program was used to perform molecular docking studies[61]. 3D crystallographic structures of the ACE2-S1 complex, Mpro, and PLpro proteins were downloaded from the Protein Data Bank

All cocrystallized ligands and waters were deleted using Discovery Studio Visualizer

The 2D structures of the compounds were drawn on ChemDraw Professional 16.0. The 2D structures of boceprevir, GRL0617, and MB were retrieved from the PubChem website

The 2D structures of all compounds were minimized using the MMFF94s force field via Avogadro software

Molecular Dynamics Simulation Molecular dynamics simulations were performed for 50 ns using Desmond[67], a Package of Schrödinger LLC

A novel coronavirus from patients with pneumonia in China

The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2

Veesler D: Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods

Characterization of the receptorbinding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Methylene blue inhibits the SARS-CoV-2 spike-ACE2 protein-protein interaction-a mechanism that can contribute to its antiviral activity against COVID-19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response

Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

Structure of papain-like protease from SARS-CoV-2 and its complexes with noncovalent inhibitors

The nonstructural proteins directing coronavirus RNA synthesis and processing

In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease

Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: an extensive study

SARS-CoV-2 papain-like protease potential inhibitors-in silico quantitative assessment

Identification of 1, 2, 3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study

Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl) indol-4-ones: Potential inhibitors of SARS CoV-2 main protease

Synthesis, Spectroscopic Characterizations of Novel Norcantharimides, Their ADME Properties and Docking Studies Against COVID-19 Mpr°

Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2, 4, 6-trimethyl-benzyl)-piperidine: Potential Inhibitor of SARS-CoV2

Srour AM: New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2. Bioorganic chemistry 2021

Standard molar enthalpies of formation and sublimation of Nphenylphthalimide

A New and Convenient Synthesis of Amino-phthalimide (1H-Isoindole-1, 3 (2H)-dione) Derivatives and Their Photoluminescent Properties

Investigation of solvent effects on photophysical properties of new aminophthalimide derivatives-based on methanesulfonate

Synthesis of N-substituted phthalimides and their antifungal activity against Alternaria solani and Botrytis cinerea

Experimental and molecular docking investigation on DNA interaction of N-substituted phthalimides: antibacterial, antioxidant and hemolytic activities

Evaluation of cytotoxic potentials of some isoindole-1, 3-dione derivatives on HeLa, C6 and A549 cancer cell lines

Synthesis, investigation of the cholinesterase inhibitory activities and in silico studies of some novel N-substituted phthalimide derivatives

Synthesis and anticonvulsant evaluation ofN-substituted-isoindolinedione derivatives

Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues

Palladium on Carbon: An Efficient, Heterogeneous and Reusable Catalytic System for Carbonylative Synthesis of N-Substituted Phthalimides

Design, click synthesis, anticancer screening and docking studies of novel benzothiazole-1, 2, 3-triazoles appended with some bioactive benzofused heterocycles

Novel 1, 2, 3-triazole compounds: Synthesis, In vitro xanthine oxidase inhibitory activity, and molecular docking studies

3-Triazoles: scaffold with medicinal significance

Ksantin Oksidaz İnhibitörü Yeni 1, 2, 3-triazol Türevlerinin Sentezi, Karakterizasyonu ve Moleküler Doking Çalışmaları

New click-chemistry methods for 1, 2, 3-triazoles synthesis: Recent advances and applications

Recent Progress in 1H-1, 2, 3-triazoles as Potential Antifungal Agents

Design, synthesis, antimicrobial evaluation and docking studies of urea-triazole-amide hybrids

Design, synthesis and in vitro anti-tuberculosis activity of benzo

A series of new medium-bandgap conjugated polymers based on naphtho

Click Synthesis and antimicrobial screening of novel isatin-1, 2, 3-triazoles with piperidine, morpholine, or piperazine moieties. Organic Preparations and Procedures International

Design and Synthesis of New Aryloxy-linked Dimeric 1, 2, 3-Triazoles via Click Chemistry Approach: Biological Evaluation and Molecular Docking Study

2-Phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors: A study on the importance of modifications at the side chain on the activity

Copper (I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates

Synthesis, antitubercular evaluation and molecular docking studies of phthalimide bearing 1, 2, 3-triazoles

3-Triazole derivatives as new cannabinoid-1 receptor antagonists

Efficient syntheses of 1, 2, 3-Triazoloamide derivatives using solid-and solution-phase synthetic approaches

Flustramine inspired synthesis and biological evaluation of pyrroloindoline triazole amides as novel inhibitors of bacterial biofilms

Synthesis of (1 H-1, 2, 3-Triazol-1-yl) acetic Acid Derivatives

Highly accelerated inverse electron-demand cycloaddition of electron-deficient azides with aliphatic cyclooctynes

Biological evaluation and molecular docking studies of 4-aminobenzohydrazide derivatives as cholinesterase inhibitors

The synthesis, anticancer activity, structure-activity relationships and molecular modelling studies of novel isoindole-1, 3 (2H)-dione compounds containing different functional groups. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)

Synthesis, investigation of the cholinesterase inhibitory activities and in silico studies of some novel N-substituted phthalimide derivatives

Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

ProTox-II: a webserver for the prediction of toxicity of chemicals

Prediction is a balancing Act: importance of sampling methods to balance sensitivity and specificity of predictive models based on imbalanced chemical data sets

ProTox: a web server for the in silico prediction of rodent oral toxicity

ChemCalc: a building block for tomorrow's chemical infrastructure

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

The protein data Bank nucleic acids research

PubChem in 2021: new data content and improved web interfaces

Avogadro: an advanced semantic chemical editor, visualization, and analysis platform

VMD: visual molecular dynamics

Scalable algorithms for molecular dynamics simulations on commodity clusters

Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids

Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides

Nosé-Hoover chains: The canonical ensemble via continuous dynamics

Constant pressure molecular dynamics algorithms